Skip to content
CancerIndex

Publication

Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma.

Rafael R Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, Maria Silva, Xiaohong Zhao, Dario Magaletti, Raghunandan Reddy Alugubelli, Gabriel DeAvila, Daniel DeAvila, Erez Persi, Francesco Maura, Elissa T Bell, Ryan T Bishop, Christopher L Cubitt, Samer S Sansil, Wei Zhang, Jamie K Teer, Mingxiang Teng, Sean J Yoder, Erin M Siegel, Bijal D Shah, Taiga Nishihori, Lori Hazlehurst, Conor C Lynch, Ola Landgren, Oliver Hampton, Robert A Gatenby, Daniel M Sullivan, Jason Brayer, William Dalton, John L Cleveland, Melissa Alsina, Rachid Baz, Kenneth H Shain, Ariosto S Silva

Cancer researchSep 15, 2026PMID 42233980doi:10.1158/0008-5472.CAN-26-1082 PMC13575565Journal ArticleResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov't, Non-P.H.S.Research Support, Non-U.S. Gov'tpubmedProvenance
Source
PubMed
Retrieved
Sep 29, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260929-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

UNLABELLED: Multiple myeloma is marked by recurrent cytogenetic abnormalities and mutations that accumulate as the disease progresses. In this study, we sought to elucidate the transitions driving tumorigenesis and therapy resistance in multiple myeloma using a unique cohort of nearly 900 patients…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.